Moreover, Rumpold et al., [53] showed that a stable silencing of ABCB1 in imatinib-resistant CML cell lines abolished ABCB1-efflux substrates and induced sensibility to imatinib. Here, ABCB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.